Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Manhattan Associates Inc
XMUN:MHT
|
US |
Liaoning Chengda Biotechnology Co Ltd
Research & Development
Liaoning Chengda Biotechnology Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
|
Research & Development
-¥205.7m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Research & Development
-¥13.6B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Research & Development
-¥2.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
RemeGen Co Ltd
SSE:688331
|
Research & Development
-¥1.4B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Research & Development
-¥1.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Research & Development
-¥1.3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Liaoning Chengda Biotechnology Co Ltd
Glance View
Liaoning Chengda Biotechnology Co., Ltd. is engaged in the research, development, manufacture and sale of vaccines. The company is headquartered in Shenyang, Liaoning and currently employs 1,663 full-time employees. The company went IPO on 2021-10-28. The firm's main products include rabies vaccine for human use, freeze-dried rabies vaccine for human use, inactivated Japanese encephalitis vaccine for human use and freeze-dried encephalitis inactivated vaccine. The firm's products include two brands: Chengda Suda and Chengda Libao.
See Also
What is Liaoning Chengda Biotechnology Co Ltd's Research & Development?
Research & Development
-205.7m
CNY
Based on the financial report for Dec 31, 2024, Liaoning Chengda Biotechnology Co Ltd's Research & Development amounts to -205.7m CNY.
What is Liaoning Chengda Biotechnology Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-7%
Over the last year, the Research & Development growth was -20%. The average annual Research & Development growth rates for Liaoning Chengda Biotechnology Co Ltd have been -4% over the past three years , -7% over the past five years .
